US Edition
Published • loading... • Updated
Cofepris Issues Alert by Falsified Ozempic
Summary by Aristegui Noticias
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
COFEPRIS alerts against counterfeiting of Ozempic 1 mg in Mexico: apocryphal batch does not contain active substance, was relabelled and presents a health risk.
·Mexico City, Mexico
Read Full Article
The Federal Commission for the Protection against Health Risks (Cofepris) launched a health alert for the counterfeiting of the drug Ozempic (semaglutide), used for the treatment of type 2 diabetes and widely demanded for weight loss.According to the authority, the counterfeit product, in presentation of 1 mg in pre-filled pen, was already detected in the national market and represents a direct risk to health, as it does not meet the standards o…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
